Boundless Bio's first direct ecDNA-targeting asset, is entering clinical trials with promising preclinical efficacy. Check ...

The average one-year price target for Boundless Bio (NasdaqGS:BOLD) has been revised to $4.08 / share. This is an increase of ...

WORTHINGTON, Ohio, October 14, 2025--(BUSINESS WIRE)--I Am Boundless, Inc., a nonprofit leader in integrated care for individuals with intellectual and developmental disabilities (I/DD) and behavioral ...

Targeted therapies and immunotherapies offer new treatment options for more types of cancer, but these drugs are less helpful when tumors produce multiple copies of a gene. This gene amplification ...

Seattle-based startup Boundless laid off four employees and asked 27 workers to relocate to Las Vegas as part of what CEO Xiao Wang described as a restructuring. The online immigration service in ...

Boundless Bio has announced a strategic portfolio prioritization aimed at optimizing its oncology programs, particularly focusing on the combination therapy of BBI-355 and BBI-825, alongside a new ...

Our education system is broken, from lower-level public schools all the way up to higher learning. EdTech startups are coming at the numerous problems from every angle. Boundless, a startup out of ...

Texas-based company Monumental announced it’s acquired Boundless, an MMO from developer Turbulenz. The development studio will partner with Turbulenz on future development of the open-world sandbox ...

In April 2017, arms control experts said these Planet images showed where the United States, United Kingdom and France fired missiles on suspected chemical weapons facilities in Damascus, Syria.